Kyle Forcier, Senior Director of Life Sciences Product Marketing at Model N Shares Insights on How Model N Helps Life Sciences Companies Navigate Greater Compliance Pressure

Shots: Kyle Forcier gave a detailed view of the Spring 2022 product release by Model N and how it will be a practical solution for the Pharmaceutical and MedTech companies Kyle also spoke about Model N’s Revenue Cloud, which can empower MedTech Sales with better revenue recognition The interview gives a glimpse of Model N’s…

BySenior EditorJuly 11, 2022

EXCLUSIVE

Exclusive Interview with PharmaShots: Anita Holz of Boehringer Ingelheim And Alanna Morris of Emory University Share Insight on Hear Your Heart

In an interview with PharmaShots, Anita Holz, MSN, CRNP, Therapeutic Area Head, Cardiometabolism Medical Affairs, Boehringer Ingelheim & Alanna Morris, Associate Professor of Medicine, Division of Cardiology, Emory University School of Medicine shared their views on the launch of Hear Your Heart to provide resources and education for women with heart failure & highlight inequitable care in black and Latina women Shots: Boehringer &…

BySenior EditorMay 16, 2022

EVENTS

Exclusive Webinar: Strategies to Conduct Clinical Trials Effectively in Covid-19 Era

The Webinar on 'Strategies to Conduct Clinical Trials effectively in Covid-19 era' organized by CliniMed LifeSciences Pvt. Ltd., Kolkata in association with Indian Society for Clinical Research (ISCR) and Peerless Hospital, Kolkata as knowledge partners and PharmaShots as a media partner, was held at 3 pm on June 6, 2020. Around 500 plus participants attended…

BySenior EditorJune 18, 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in March and April 2020

The US FDA's Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 48 new products so far in 2019. However, there is a significant increase in multiple diseases while the new approvals are helping and advancing the changes to understand, diagnose, and treat the diseases Our team…

BySenior EditorMay 15, 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in February 2020

The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 13 novel products so far in 2020, including 10 in Feb and 3 in Jan…

BySenior EditorMarch 27, 2020

EVENTS

Exclusive Coverage: Key Takeaways from the DIA India Medical Devices Conference 2020

The DIA India Medical Devices Conference 2020 is the first effort of DIA India to bring together leaders from the medical devices industry, regulatory and academia from India in New Delhi to discuss the current landscape and regulatory updates of the medical devices industry. New upcoming medical devices regulations, changing landscapes and the evolution of…

ByadminMarch 2, 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in November 2019

The US FDA's Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 35 new products so far in 2019. In 2018 FDA approved 59 novel products including 42 New Chemical Entities and 17 Biologics while breaking its last year's record of approvals. However, there is a significant…

BySenior EditorDecember 13, 2019

Kyle Forcier, Senior Director of Life Sciences Product Marketing at Model N Shares Insights on How Model N Helps Life Sciences Companies Navigate Greater Compliance Pressure

Exclusive Interview with PharmaShots: Anita Holz of Boehringer Ingelheim And Alanna Morris of Emory University Share Insight on Hear Your Heart

Exclusive Webinar: Strategies to Conduct Clinical Trials Effectively in Covid-19 Era

Insights+: The US FDA New Drug Approvals in March and April 2020

Insights+: The US FDA New Drug Approvals in February 2020

Exclusive Coverage: Key Takeaways from the DIA India Medical Devices Conference 2020

Insights+: The US FDA New Drug Approvals in November 2019

Contact US

OUR INFORMATION

FOLLOW US